Pipeline· May 27, 2026 · 7 min read
Antibody-drug conjugate access landscape: 14 FDA-approved ADCs, payer coverage, and the pipeline watch
By Ran Chen#ADC#HER2#Prior Authorization
Topic
HER2
HER2-targeted therapy, oncology biosimilars, antibody-drug conjugates, coding, and access strategy.